Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
This is like a phoenix rising from the ashes. All that has gone before does not count,after the deal is done & dusted this will be a new company with a new director.
2.5 times your money is allot more than what you currently have. You need to find a new investment strategy so not to have such huge loses. Let your profits run & cut your losses etc. Read more books,so you find a strategy that works for you.
So 2.5 times your money is not enough? Could do that within months. If your brave enough you could hold on until January when there products come to market. If proven successful you could be talking telephone numbers.
.20P buyer. Look like BMD price target of .25P is a bit low,could do that by end of week.
Allot of buyers at .19p,got to brake .20 today. Another delayed trade,10Million shares.
I think when the company announces a major contract win or sign a new partner they will increase there target price. With the current buying we might get to .25 by Friday or 25p when shares are consolidated.
I agree,there target is a bit low,considering the director cant sell until 50p. Reckon it could go beyond there target by end of week. Should be more buyers reading the newsletter as they get home from work & buying in tomorrow.
There was a delayed 20 Million trade,not sure if it was a buy or sell at 16.31.
Adam Reynolds has a very big option package which only kicks in if the shares trade above 0.5p (50p post consolidation) for 30 consecutive days. As a promoter of repute we expect him to work his socks off from the moment the EGM is over to get his options. The Trade: Buy at 0.17p and up to 0.2p with a one month target to sell of 0.255p. -----
The June tip of the Month: Buy Vialogy at a 0.17p offer – one month target 0.255p to sell Not one but three members of the HotStockRockets team have interests in this stock but we will not sell until at least 24 hours after advising you to do so. And we reckon that if you buy today you will be making a 50% return within a month. Vialogy (LSE:VIY) is our tip of the month at a 0.17p offer. This AIM listed company used to be a total joke of a lifestyle company, pretending that it had new technology in oil. Thankfully at death’s door it was rescued by well-known turnaround/cash shell expert Adam Reynolds. The shares came back from suspension a couple of weeks ago as Reynolds announced a transformational RTO. That will be ratified at an EGM this Thursday which will also approve a 100 for 1 share consolidation (which will narrow the spread) and a change of name to Premaitha. The maths. The company raised £6.5 million at 0.11p. It also issued £10.5 million of shares at 0.11p to buy Premaitha. The shareholders of Premaitha are locked in and the placees are all institutional so can’t flip like a private investor and so are effectively locked in. The placing was FOUR times oversubscribed. Thus with another institutional placing done earlier this year by Reynolds the free float is sub 10%. The shares have been hit since the return from suspension by some in the free float selling ordinaries to pay for participation in a 1 for 4 open offer. There is now no time left for any more such flipping. The market capitalisation is now – at 0.17p to buy – £29 million and net cash is c£8 million. So how do you justify an EV of £21 million? Easy. 1. Management. The Premaitha team is headed up by an accomplished CEO Stephen Little but also has on board David Evans. Many years ago he turned Axis Shield from a penny stock into an £8 stock. He knows this industry and has a mass City following so we expect institutional buying post the EGM 2. The company is working on the final development and commercialisation of a non-invasive pre-natal screening test for Down’s syndrome developed by Premaitha. This is a massive market. Of course there are risks in medical technology but we back Evans and the size of this global market is estimated to be $4.2 billion. We are assured that Vialogy needs no more ash to get its product to market and you do not need much of a market share to justify the EV here. Reasons to buy now: 1. The shares have been depressed by small investors selling ordinaries to take up the open offer. That process is now over. 2. Management. Enough said. 3. Post EGM we expect institutional buying from those who were massively scaled back in the placing and there is a relatively small free float. 4. We expect that with a news blackout for several months there is a pipeline of RNS announcements which will start very soon after the EGM 5. Adam Reynolds has a very big option package which only kicks in if
Surprised by the retrace after such positive news. They are currently a UK company that will going world wide. They sell in B&Q,Amazon,Maplins & many more stores in the UK.
I think some investors who get home tonight will read the hot-stock news letter & buy in tomorrow morning. So might see even bigger rises tomorrow. Might push .20p by closing.
Current market cap around £4 Million,they will have around £8 Million in the bank when deal is done & dusted. It will be a new company with assets of the company there taking over. So stand to reason they will be worth more. They has a fund rasing that was %400 over subscribed. Don't think even royal mail did that well.
Not sure if you have to sign up to view the original link. You can even message BMD if you become a member. He calls me moaning gecko. http://guerillainvesting.co.uk/2014/06/26/vialogy-im-in-for-a-spin/
As a general rule of thumb we here at the world’s most infamous, libellous blog don’t usually cover stocks outside of the oil & gas/mining sectors. So it should be a surprise to learn that after slating SOFTWARE & COMPUTER SERVICES AIM listed Vialogy (VIY) shares when the “other lot” were in charge we are now or should I say ‘I have now increased my original token holding” and here’s why. The new improved Vialogy came back from restructuring/suspension a far healthier body politick, the tumour that was killing the Company has been excised. There is new life and where’s there’s life there is hope. Especially when Institutions have piled in en-mass because the new ‘cheeky chappies’ in charge have done exactly what they’ve promised to do here, before, a turnaround, making money for share-holders. The company rescuers are Adam Reynolds, David Evans and Stephen Little from Premaitha. A well-respected triumvirate! Suggest those that are looking for a quick spin. Do their sums. The recent £6.5 million placing at 0.11p. was FOUR TIMES oversubscribed with a raft of institutions now on board. I never took part in that placing because I was too busy with other matters and no one approached me! But I have bought in at a significantly higher price. “Vialogy has conditionally acquired the entire issued share capital of Premaitha, which is a molecular diagnostic company. The consideration of £10.5 million is to be satisfied by the issue of 95,454,545 New Ordinary Shares at a price of 11 pence per share. The Company has raised £6.5 million (before expenses) by means of the Placing and intends to raise up to a further £0.7 million by means of the Open Offer. The net proceeds of the Placing and the Open Offer will be used to develop and commercialize the IONA® Test, a non-invasive pre-natal screening test for Down’s Syndrome developed by Premaitha, and for general working capital purposes. The Acquisition, if completed, is of sufficient size to constitute a reverse takeover under the AIM Rules and therefore is subject to the approval of shareholders at a General Meeting to be held at 11.00 a.m. on 3 July 2014 at the offices of Panmure Gordon (UK) Limited, One New Change, London EC4M 9AF” Premaitha are working on the final development and commercialisation of a non-invasive pre-natal screening test for Down’s syndrome developed by Premaitha. The market for this is very, very large. $4.2 billion. Once the consolidation and proposals go through basically a foregone conclusion Vialogy will have £8,000,000 million in cash. In order for Adam Reynolds to take his options package at 0.1p or 10p post consolidation Vialogy would have to have been trading at above 0.5p or 50p post consolidation for 30 consecutive days. That speaks volumes to me. If Reynolds believes he can do this then I know that the Board are rolling their
BrokcermanDaniel tipped the share a few days before. Huge potential here. They where %400 oversubscribed on a recent fund raising.
Im already in profit after one day,great place to be. Volume is going up allot. Now is time to buy before this goes ballistic.
This is a huge deal for a company this size. Was in the company before the name change. They had some technical problems with there heating range which is now sorted out. The reviews on there products on Amazon etc are very positive. Neonlite market their products under the Megaman brand which is a global brand in high-performance, energy-efficient lighting and an innovative leader in LED and CFL lamp design, with technology targeting the best eco-lighting solutions. MEGAMAN® products are widely distributed throughout the world, including Europe, Asia Pacific, Middle East, Africa and South America, covering more than 90 countries. By setting environmental management as one of the company's highest priorities, MEGAMAN® is focusing on eco-friendly environmental processes from initial design, to manufacturing, research and development, and the disposal and recycling of its products.
Nominal value means nothing,its the market value that counts.
.17P buyer.looking good for next push up today.